PDL BioPharma, Inc. Operating Cash Flow

Operating Cash Flow of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow growth rates and interactive chart. Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations, otherwise it may require external financing for expansion or even survival. A negative number means the company is funded through external capital (debt or equity issuance) or cash available on the balance sheet. A positive number means that a company generates enough cash to pay for its operations.


Highlights and Quick Summary

  • Operating Cash Flow for the quarter ending June 29, 2020 was $-20.2 Million (a 32.46% increase compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow decreased by -40.54%
  • Annual Operating Cash Flow for 2019 was $-32.4 Million (a 141.66% increase from previous year)
  • Annual Operating Cash Flow for 2018 was $-13.4 Million (a -133.05% decrease from previous year)
  • Annual Operating Cash Flow for 2017 was $40.6 Million (a -60.06% decrease from previous year)
  • Twelve month Operating Cash Flow ending June 29, 2020 was $-88.6 Million (a 95.14% increase compared to previous quarter)
  • Twelve month trailing Operating Cash Flow increased by 476.52% year-over-year
Trailing Operating Cash Flow for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-88.6 Million $-45.4 Million $-32.4 Million $-15.4 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow of PDL BioPharma, Inc.

Most recent Operating Cash Flowof PDLI including historical data for past 10 years.

Interactive Chart of Operating Cash Flow of PDL BioPharma, Inc.

PDL BioPharma, Inc. Operating Cash Flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-20.21 $-15.25
2019 $-19.14 $-33.98 $22.98 $-2.3 $-32.44
2018 $-2.07 $8.4 $-6.24 $-13.52 $-13.43
2017 $-17.44 $-3.55 $15.83 $45.78 $40.62
2016 $15.65 $-8.69 $2.25 $92.51 $101.72
2015 $70.08 $75.49 $84.05 $71.85 $301.47
2014 $69.04 $77.09 $78.01 $68.14 $292.28
2013 $61.21 $45.83 $109.85 $52.86 $269.75
2012 $53.88 $35.83 $104.9 $17.9 $212.51
2011 $45.15 $36.71 $101.08 $-13.15 $169.78
2010 $29.99 $30.69 $96.69 $184.3

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.